Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Case report

Rare co-occurrence of multiple sclerosis and Wilson’s disease – case report

Authors: Katalin Despotov, Péter Klivényi, István Nagy, Attila Pálvölgyi, László Vécsei, Cecília Rajda

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Wilson’s disease is a hereditary disorder of copper metabolism resulting mainly in hepatic, neurological, and psychiatric symptoms. Multiple sclerosis (MS) is an immune-mediated demyelinating disease affecting the central nervous system (CNS). The co-occurrence of these two, although not unheard of in literature, is still considered to be very rare and can give rise to diagnostic difficulties. Also, comorbidity in MS highly influences quality of life and disease progression, which makes the timely diagnosis and treatment of these conditions essential.

Case presentation

The aim of this study is to present a patient exhibiting symptoms of both MS and Wilson’s disease, as well as to conduct a detailed review of previously reported cases. The patient’s neurological symptoms (sensory disorder) as well as MRI and CSF findings were characteristic for MS. The diagnosis of MS preceded that of Wilson’s disease and was relatively mild in course. Currently, the patient receives cladribine as an immunomodulatory treatment after escalation from glatiramer acetate therapy. Apart from one episode of acute hepatic decompensation, during which transfusion, albumin supplementation and diuretic treatment was necessary, Wilson’s disease manifested as chronic impairment of liver function. The diagnosis of Wilson’s disease was established by the analysis of serum coeruloplasmin levels, histological examination and genetic findings. Continuous oral penicillamine therapy led to the slow normalization of hepatic function and significant amelioration of the patient’s symptoms. Correlating with cases previously reported, the course of MS was relatively mild, and like in three out of four other known cases, the symptoms of Wilson’s disease were mostly restricted to hepatic dysfunction.

Conclusion

The case presented in our report is similar to those reported before. The co-occurrence of the two diseases seems to be more a coincidence than a sharing of common factors in their pathogenesis; however, they are considered to influence one another. Regarding rare co-occurrences such as this one, every new case is of high importance, as it enables a better evaluation and understanding of the clinical presentations that are more characteristic of these cases, thus aiding the estimation of disease course as well as possible therapeutic choices.
Literature
1.
go back to reference European Association for the Study of the Liver. EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–85.CrossRef European Association for the Study of the Liver. EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–85.CrossRef
2.
go back to reference Folhoffer A, Ferenci P, Csák T, Horváth A, Hegedûs D, Firneisz G, et al. Genetic and clinical characteristics of Wilson disease in patients from Hungary. Z Gastroenterol. 2008;46(5):A20. Folhoffer A, Ferenci P, Csák T, Horváth A, Hegedûs D, Firneisz G, et al. Genetic and clinical characteristics of Wilson disease in patients from Hungary. Z Gastroenterol. 2008;46(5):A20.
3.
go back to reference Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.CrossRef Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.CrossRef
4.
go back to reference Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61(4):288–99.CrossRef Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61(4):288–99.CrossRef
5.
go back to reference Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007;61(6):504–13.CrossRef Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007;61(6):504–13.CrossRef
6.
go back to reference Rajda C, Bencsik K, Seres E, Jonasdottir A, Foltynie T, Sawcer S, et al. A genome-wide screen for association in Hungarian multiple sclerosis. J Neuroimmunol. 2003;143(1–2):84–7.CrossRef Rajda C, Bencsik K, Seres E, Jonasdottir A, Foltynie T, Sawcer S, et al. A genome-wide screen for association in Hungarian multiple sclerosis. J Neuroimmunol. 2003;143(1–2):84–7.CrossRef
7.
go back to reference Dzieżyc K, Litwin T, Członkowska A. Multiple sclerosis in two patients with coexisting Wilson’s disease. Mult Scler Relat Disord. 2014;3(3):387–90.CrossRef Dzieżyc K, Litwin T, Członkowska A. Multiple sclerosis in two patients with coexisting Wilson’s disease. Mult Scler Relat Disord. 2014;3(3):387–90.CrossRef
8.
go back to reference Günther P, Baum P, Then BF. Morbus Wilson und multiple Sklerose. Nervenarzt. 2010;81(2):226–8.CrossRef Günther P, Baum P, Then BF. Morbus Wilson und multiple Sklerose. Nervenarzt. 2010;81(2):226–8.CrossRef
9.
go back to reference Yetkin MF, Mirza M, Gursoy S. Multiple sclerosis and Wilson disease: a rare coincidence. Clin Neurol Neurosurg. 2019;186:105507.CrossRef Yetkin MF, Mirza M, Gursoy S. Multiple sclerosis and Wilson disease: a rare coincidence. Clin Neurol Neurosurg. 2019;186:105507.CrossRef
10.
go back to reference Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.CrossRef Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.CrossRef
11.
go back to reference Ranjan A, Kalita J, Kumar S, Bhoi SK, Misra UK. A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg. 2015;138:31–6.CrossRef Ranjan A, Kalita J, Kumar S, Bhoi SK, Misra UK. A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg. 2015;138:31–6.CrossRef
12.
go back to reference Trocello JM, Guichard JP, Leyendecker A, Pernon M, Chaine P, El Balkhi S, et al. Corpus callosum abnormalities in Wilson’s disease. J Neurol Neurosurg Psychiatry. 2011;82(10):1119–21.CrossRef Trocello JM, Guichard JP, Leyendecker A, Pernon M, Chaine P, El Balkhi S, et al. Corpus callosum abnormalities in Wilson’s disease. J Neurol Neurosurg Psychiatry. 2011;82(10):1119–21.CrossRef
13.
go back to reference Zhou ZH, Wu YF, Cao J, Hu JY, Han YZ, Hong MF, et al. Characteristics of neurological Wilson’s disease with corpus callosum abnormalities. BMC Neurol. 2019;19(1):1–5. Zhou ZH, Wu YF, Cao J, Hu JY, Han YZ, Hong MF, et al. Characteristics of neurological Wilson’s disease with corpus callosum abnormalities. BMC Neurol. 2019;19(1):1–5.
14.
go back to reference Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson’s disease. J Clin Neurosci. 2019;59:167–74.CrossRef Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson’s disease. J Clin Neurosci. 2019;59:167–74.CrossRef
15.
go back to reference Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol. 2016;43:1–8.CrossRef Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol. 2016;43:1–8.CrossRef
16.
go back to reference Gromadzka G, Schmidt HHJ, Genschel J, Bochow B, Rodo M, Tarnacka B, et al. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson’s disease. Mov Disord. 2006;21(2):245–8.CrossRef Gromadzka G, Schmidt HHJ, Genschel J, Bochow B, Rodo M, Tarnacka B, et al. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson’s disease. Mov Disord. 2006;21(2):245–8.CrossRef
17.
go back to reference Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol. 2016;172(1):3–13.CrossRef Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol. 2016;172(1):3–13.CrossRef
Metadata
Title
Rare co-occurrence of multiple sclerosis and Wilson’s disease – case report
Authors
Katalin Despotov
Péter Klivényi
István Nagy
Attila Pálvölgyi
László Vécsei
Cecília Rajda
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02691-5

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue